ES8802370A1 - Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente. - Google Patents

Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente.

Info

Publication number
ES8802370A1
ES8802370A1 ES554144A ES554144A ES8802370A1 ES 8802370 A1 ES8802370 A1 ES 8802370A1 ES 554144 A ES554144 A ES 554144A ES 554144 A ES554144 A ES 554144A ES 8802370 A1 ES8802370 A1 ES 8802370A1
Authority
ES
Spain
Prior art keywords
sensitive adhesive
pressure
tape
delivery system
nitroglycerin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554144A
Other languages
English (en)
Other versions
ES554144A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of ES554144A0 publication Critical patent/ES554144A0/es
Publication of ES8802370A1 publication Critical patent/ES8802370A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE UN MATERIAL LAMINAR PARA EL SUMINISTRO TRANSDERMICO CONTINUO DE NITROGLICERINA (NTG), QUE COMPRENDE: A) FORMAR UNA MEZCLA HOMOGENEA DE NTG, UN POLIMERO ACRILICO, UN ESTER DE ACIDO GRASO Y MONOLAURATO DE GLICERINO; B) SECAR O REVESTIR EN HUMEDO LA MEZCLA HOMOGENEA SOBRE UN REVESTIMIENTO DE DESPRENDIMIENTO; C) SECAR LA MEZCLA HOMOGENEA COLADA O REVESTIDA; Y D) LAMINAR LA MEZCLA HOMOGENEA SECA SOBRE UN SOPORTE FLEXIBLE QUE SOLO PERMITE UNA ABSORCION MINIMA DE NTG. TIENE APLICACION COMO MEDICAMENTO PARA EL TRATAMIENTO DE LA ANGINA DE PECHO, PARTICULARMENTE PARA SU TRATAMIENTO PROFILACTICO.
ES554144A 1985-04-19 1986-04-18 Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente. Expired ES8802370A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,215 US4751087A (en) 1985-04-19 1985-04-19 Transdermal nitroglycerin delivery system

Publications (2)

Publication Number Publication Date
ES554144A0 ES554144A0 (es) 1988-05-16
ES8802370A1 true ES8802370A1 (es) 1988-05-16

Family

ID=24913627

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554144A Expired ES8802370A1 (es) 1985-04-19 1986-04-18 Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente.

Country Status (14)

Country Link
US (1) US4751087A (es)
EP (1) EP0219539B1 (es)
JP (1) JP2588180B2 (es)
AT (1) ATE76736T1 (es)
AU (1) AU593810B2 (es)
CA (1) CA1273871A (es)
CZ (1) CZ390591A3 (es)
DE (1) DE3685545T2 (es)
ES (1) ES8802370A1 (es)
IE (1) IE59725B1 (es)
IL (1) IL78527A (es)
NZ (1) NZ215746A (es)
WO (1) WO1986006281A1 (es)
ZA (1) ZA862945B (es)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422118A (en) * 1986-11-07 1995-06-06 Pure Pac, Inc. Transdermal administration of amines with minimal irritation and high transdermal flux rate
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
JP2931002B2 (ja) * 1988-02-26 1999-08-09 ライカー ラボラトリース インコーポレーテッド 皮膚透過エストラジオールデリバリーシステム
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
US4994278A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
CA2000401C (en) * 1988-10-11 1996-05-28 Masato Azuma Percutaneous pharmaceutical preparation
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5736553A (en) * 1988-12-15 1998-04-07 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
US5238944A (en) * 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
EP0436203B1 (en) * 1989-12-28 1996-04-03 Nitto Denko Corporation Percutaneous gel preparation
US5204109A (en) * 1989-12-28 1993-04-20 Nitto Denko Corporation Percutaneous gel preparation
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
JP2820306B2 (ja) * 1990-02-27 1998-11-05 積水化学工業株式会社 経皮吸収製剤
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
CA2039586A1 (en) * 1990-05-02 1991-11-03 Marian R. Appelt Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
US5122383A (en) * 1991-05-17 1992-06-16 Theratech, Inc. Sorbitan esters as skin permeation enhancers
HU210334B (en) * 1991-06-10 1995-03-28 Lohmann Therapie Syst Lts Process for production of nitroglycerine plaster
US5273755A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
JP2539330B2 (ja) * 1993-05-11 1996-10-02 日東電工株式会社 医療用粘着剤及びこれを用いて形成された医療用外用材
EP0707465A4 (en) * 1993-07-08 1997-04-16 Cygnus Therapeutic Systems MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
GB2292520B (en) * 1994-08-25 1998-09-02 Univ Sheffield Transdermal dressings for animals
JP4102901B2 (ja) * 1994-09-14 2008-06-18 スリーエム カンパニー 経皮薬剤導入用マトリックス
JP3604177B2 (ja) * 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
AU732803B2 (en) * 1996-01-17 2001-05-03 National Starch And Chemical Investment Holding Corporation Adhesives resistant to skin-penetration enhancers
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
JP2002505676A (ja) * 1997-06-23 2002-02-19 クイーンズ ユニバーシティー アット キングストン 微量投与療法
DE69833000T2 (de) 1997-09-26 2006-09-07 Noven Pharmaceuticals, Inc., Miami Bio-klebemittelzusammensetzungen
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
AU1728099A (en) 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
DE19818955C2 (de) * 1998-04-28 2000-06-29 Lohmann Therapie Syst Lts Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat
DE19830648A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
US6160086A (en) * 1998-07-30 2000-12-12 3M Innovative Properties Company Process for removing impurities from polymers
MXPA01001752A (es) 1998-08-20 2002-04-08 3M Innovative Properties Co Parche en aerosol y sistema de aplicacion de medicamento.
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
AU2002232471A1 (en) * 2000-10-31 2002-05-15 Nutrition 21, Inc. Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
RU2334744C2 (ru) 2002-03-08 2008-09-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Макроциклические соединения, которые могут быть использованы в качестве фармацевтических препаратов
CN100340395C (zh) 2002-08-30 2007-10-03 阿尔扎公司 多层层压背衬结构体
WO2004112760A1 (ja) 2003-06-24 2004-12-29 Saitama Daiichi Pharmaceutical Co., Ltd. 医療用経皮吸収テープ製剤用非水性粘着剤並びに医療用経皮吸収テープ製剤およびその製造法
DE10340428B4 (de) 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
JP4881006B2 (ja) * 2004-01-20 2012-02-22 ニプロパッチ株式会社 ツロブテロール貼付剤
ES2650188T3 (es) 2004-06-10 2018-01-17 3M Innovative Properties Company Dispositivo y kit de aplicación de parches
WO2006017632A1 (en) * 2004-08-04 2006-02-16 Cassel Douglas R An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain
EP1802665B1 (en) * 2004-10-19 2009-08-05 3M Innovative Properties Company Method for the manufacture of pressure sensitive adhesives
CN101080244B (zh) * 2004-12-15 2011-06-08 尼普洛外用药品株式会社 医用贴剂
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
GT200600396A (es) * 2005-09-07 2007-04-23 Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
US20070259026A1 (en) * 2006-04-20 2007-11-08 Robert Ang Vasodialating dressing for use with intravenous catheters
US20070248657A1 (en) * 2006-04-25 2007-10-25 Smith David J Multi-compartment transdermal pain control device
NO343857B1 (no) * 2006-07-18 2019-06-24 Meda Ab Immunresponsmodifiserende skumformuleringer
CA2659733A1 (en) * 2006-07-31 2008-02-07 3M Innovative Properties Company Sterilized topical compositions of 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine
EP2115140B8 (en) * 2007-01-31 2017-01-25 Chongxi Yu Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US20100160368A1 (en) * 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
DK2378876T3 (en) 2008-12-19 2019-03-11 Medicis Pharmaceutical Corp IMIQUIMOD FORMULATIONS WITH LOWER DOSAGE STRENGTH AND SHORT-TERM DOSAGE PLAN FOR TREATMENT OF ACTINIC KERATOSIS
MX336923B (es) 2009-07-13 2016-02-05 Medicis Pharmaceutical Corp Formulaciones de imiquimod de concentracion de dosificacion inferior y regimenes de dosificacion cortos para tratar verrugas genitales y perianales.
RU2543639C2 (ru) * 2009-09-07 2015-03-10 Нипро Пэтч Ко., Лтд. Чрескожно всасывающийся препарат
AU2011270724B2 (en) 2010-06-25 2016-10-06 Medicis Pharmaceutical Corporation Combination therapy with cryosurgery and low dosage strength imiquimod to treat actinic keratosis
EP2790684B1 (en) 2011-12-16 2016-10-12 3M Innovative Properties Company Foldable adhesive composite dressing
BR112014014828A2 (pt) 2011-12-21 2017-06-13 3M Innovative Properties Co conjunto de emplastros adesivos com revestimento de sobreposição e sistema e método para a produção do mesmo
WO2013096026A1 (en) 2011-12-21 2013-06-27 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
US20140004204A1 (en) * 2012-06-29 2014-01-02 University Of South Florida Biocompatible polyacrylate compositions and methods of use
EP2906284B8 (en) 2012-10-10 2021-01-20 Kindeva Drug Delivery L.P. Force-controlled applicator for applying a microneedle device to skin
WO2014078545A1 (en) 2012-11-16 2014-05-22 3M Innovative Properties Company Force-controlled applicator for applying a microneedle device to skin
US20160271380A1 (en) 2013-03-22 2016-09-22 3M Innovative Properties Company Microneedle applicator comprising a counter assembly
EP3003458B1 (en) 2013-05-31 2019-12-04 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
WO2014193729A1 (en) 2013-05-31 2014-12-04 3M Innovative Properties Company Microneedle injection apparatus comprising an inverted actuator
JP6494601B2 (ja) 2013-05-31 2019-04-03 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードル注射及び注入装置並びにその使用方法
CN105491982B (zh) 2013-08-12 2019-09-10 3M创新有限公司 用于增强透皮递送的肽
EP3020398A1 (en) 2014-11-17 2016-05-18 Nitto Denko Corporation Compounds and formulations for reducing scarring
EP3411023A1 (en) 2016-02-05 2018-12-12 3M Innovative Properties Company Transdermal drug delivery systems with fluorosilicone release liners
EP3287462A1 (en) 2016-08-25 2018-02-28 Nitto Denko Corporation Isosorbide derivatives to treat bacterial biofilms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS58913A (ja) * 1981-06-26 1983-01-06 Nitto Electric Ind Co Ltd 局所系医薬製剤
US4542013A (en) * 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
US4585452A (en) * 1983-04-12 1986-04-29 Key Pharmaceuticals, Inc. Transdermal systemic dosage forms
JPS59199628A (ja) * 1983-04-25 1984-11-12 Sekisui Chem Co Ltd 貼付剤
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU576889B2 (en) * 1984-07-24 1988-09-08 Key Pharmaceuticals, Inc. Adhesive transdermal dosage layer

Also Published As

Publication number Publication date
EP0219539B1 (en) 1992-06-03
US4751087B1 (es) 1993-03-02
ES554144A0 (es) 1988-05-16
AU593810B2 (en) 1990-02-22
IL78527A (en) 1991-07-18
US4751087A (en) 1988-06-14
JP2588180B2 (ja) 1997-03-05
DE3685545T2 (de) 1992-12-24
IL78527A0 (en) 1986-08-31
ATE76736T1 (de) 1992-06-15
NZ215746A (en) 1989-08-29
JPS62502965A (ja) 1987-11-26
CZ390591A3 (en) 1993-07-14
CA1273871A (en) 1990-09-11
IE861035L (en) 1986-10-19
WO1986006281A1 (en) 1986-11-06
IE59725B1 (en) 1994-03-23
EP0219539A1 (en) 1987-04-29
ZA862945B (en) 1987-12-30
AU5772586A (en) 1986-11-18
DE3685545D1 (de) 1992-07-09

Similar Documents

Publication Publication Date Title
ES8802370A1 (es) Procedimiento de obtencion de un material laminar para el suministro transdermico continuo de nitroglicerina a un paciente.
AU2097892A (en) Transdermal estradiol delivery system
AU533491B2 (en) Bandage for administering drugs to the skin
ATE69720T1 (de) Transdermales system fuer timolol.
MY103740A (en) Transdermal therapeutic system
ATE42901T1 (de) Haftendes arzneimittelpraeparat fuer perkutane absorption.
AU7803587A (en) Transdermal therapeutic system, its use and production process
AU3893889A (en) A novel discontinuous adhesive surface
GB2256367B (en) Transdermal administration of salts of medetomidine
ES8900038A1 (es) Metodo de fabricacion de un dispositivo medico para la administracion transdermica de elevado flujo de nitroglicerina a traves de una zona predeterminada de la piel
AU622775B2 (en) A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
EP0138551A3 (en) A system for the transdermal delivery of nitroglycerin
AU3772989A (en) Penetration enhancers for transdermal delivery of systemic agent
AU3740589A (en) Penetration enhancers for transdermal delivery of systemic agents
CA2010225A1 (en) Therapeutic System for the Retarded and Controlled Transdermal or Transmucous Administration of Active Substances (1)
PT1011674E (pt) Sistema terapeutico transdermico com a substancia activa escopolamina base
ES8800609A1 (es) Procedimiento de obtencion de un parche para la administracion transdermica de agentes farmacologicamente activos.
TW273516B (en) Adhesive matrix-type transdermal therapeutic set for motion sickness
PL256235A2 (en) Method of anchoring synthetic polymer substrate foils intended to be coated with pressure-sensitive adhesives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100623